Download PDF
1 / Pages

Other users also viewed these articles

Proprotein convertase subtilisin/kexin type 9 inhibitors in secondary prevention of vascular events in patients with stroke: Consensus document and practice guidance A. Gil-Núñez; J. Masjuan; J. Montaner; M. Castellanos; T. Segura; P. Cardona; J.I. Tembl; F. Purroy; J. Arenillas; E. Palacio;
Neurologia. 2022;37:136-50
Use of cardiovascular polypills for the secondary prevention of cerebrovascular disease J. Masjuan; J. Gállego; J.M. Aguilera; J.F. Arenillas; M. Castellanos; F. Díaz; J.C. Portilla; F. Purroy;
Neurologia. 2021;36:1-8
Paediatric stroke in the northern Spanish region of Aragon: incidence, clinical characteristics, and outcomes Á. Lambea-Gil; A.L. Martínez-de-Morentín-Narvarcorena; H. Tejada-Meza; D. Zapatero-González; P. Madurga-Revilla; M. Bestué-Cardiel;
Neurologia. 2024;39:474-85